MATE1 was also determined to mediate transport of Tofacitinib, a blocker of the ATP-binding side of Janus kinase (JAK) proteins and tyrosine kinase inhibitor, from RA FLS (68). The gene discussed is SLC47A1; the disease is rheumatoid arthritis.